Neuroscience Drug Discovery Congress29 - 30 July 2020 | CEST (UTC+2)
The Congress will bring together a host of key experts, examining the latest advances in neuroscience research, both in target identification & validation-led approaches
The Neuroscience Drug Discovery Congress includes...
Over 350 discovery delegates as part of the R&D Series EU, representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic & research institutions
Over 20 presentations and case studies focussing on the emerging trends and technological breakthroughs in neuroscience discovery
Discuss the pioneering innovations for in vitro and in vivo disease modelling, as well as future applications of stem cell technologies, including iPS cells
Explore cutting-edge developments in gene therapy for CNS drug discovery and current opportunities for biomarker development in neuroscience
Agenda at a Glance